Ajooni Biotech website updated per SEBI LODR Regulation 46

0 min read     Updated on 15 Jul 2026, 03:06 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Ajooni Biotech Limited confirmed its website is updated and functional in compliance with Regulation 46 of the SEBI (LODR) Regulations, 2015. The official website is www.ajoonibiotech.com. Managing Director Jasjot Singh submitted the undertaking to the National Stock Exchange on July 14, 2026.

powered bylight_fuzz_icon
45610564

*this image is generated using AI for illustrative purposes only.

Ajooni Biotech Limited confirmed to the National Stock Exchange that its official website is updated and fully functional, complying with Regulation 46 of the SEBI (LODR) Regulations, 2015. The disclosure ensures the company meets the necessary corporate governance standards regarding information dissemination to shareholders and the public.

The company specified that its official web address is www.ajoonibiotech.com . This platform serves as the primary source for statutory disclosures and corporate information required under the regulations.

Compliance Details

The undertaking was formally submitted to the exchange to update the company's records regarding its digital compliance status.

Detail Information
Regulation SEBI (LODR) Regulations, 2015, Reg. 46
Website www.ajoonibiotech.com
ISIN INE820Y01021
Symbol AJOONI

The communication was addressed to the National Stock Exchange of India Ltd at its Bandra-Kurla Complex office in Mumbai. The confirmation was signed by Jasjot Singh, Managing Director of Ajooni Biotech Limited , on July 14, 2026.

Historical Stock Returns for Ajooni Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.50%+1.27%+8.99%+2.83%-27.93%-57.54%

What specific digital enhancements or features does Ajooni Biotech plan to implement to further improve transparency for shareholders?

How will the company ensure continuous compliance with SEBI regulations as digital disclosure requirements evolve?

Could this compliance update signal upcoming corporate actions, such as a new share issuance or dividend announcement?

Ajooni Biotech to hold 16th AGM on July 29, 2026

1 min read     Updated on 02 Jul 2026, 05:53 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Ajooni Biotech has announced its 16th Annual General Meeting for July 29, 2026, via video conferencing. The agenda includes adopting audited financial statements for FY26 and re-appointing a director. Special resolutions propose increasing authorised share capital from ₹50 crore to ₹70 crore and issuing up to 90,00,000 shares to promoter Healthy Biosciences Limited at ₹4.30 per share to raise ₹3.87 crore for infrastructure development.

powered bylight_fuzz_icon
44319103

*this image is generated using AI for illustrative purposes only.

Ajooni Biotech has scheduled its 16th Annual General Meeting (AGM) for July 29, 2026, to be held through video conferencing. The meeting will transact ordinary business, including the adoption of audited financial statements for the year ended March 31, 2026, and the re-appointment of Director Gursimran Singh. Shareholders will also vote on special resolutions to increase the company's authorised share capital and issue equity shares on a preferential basis to a promoter.

The Board proposes to increase the authorised share capital from ₹50 crore to ₹70 crore by creating an additional 10 crore equity shares of ₹2 each. Additionally, the company seeks approval to allot up to 90,00,000 equity shares to Healthy Biosciences Limited, a promoter, at a price of ₹4.30 per share, including a premium of ₹2.30. The issue aims to raise ₹3.87 crore, primarily for constructing storage godowns and general corporate purposes.

Key AGM Dates

Event Date
AGM Date July 29, 2026
Book Closure Start July 23, 2026
Book Closure End July 29, 2026
Cut-off Date for E-voting July 17, 2026
Remote E-voting Start July 25, 2026
Remote E-voting End July 28, 2026

The register of members and share transfer books will remain closed from July 23, 2026, to July 29, 2026, to determine shareholder eligibility. The cut-off date for ascertaining eligibility for remote e-voting and polling is July 17, 2026. National Securities Depositories Limited (NSDL) will provide the remote e-voting facility.

Proposed Preferential Allotment Details

Particulars Details
Allottee Healthy Biosciences Limited
Number of Shares 90,00,000
Face Value ₹2 per share
Issue Price ₹4.30 per share
Premium ₹2.30 per share
Total Amount ₹3.87 crore

The preferential allotment is subject to the approval of shareholders by way of a special resolution. The relevant date for determining the minimum issue price is June 29, 2026. The company intends to complete the allotment within 15 days of receiving necessary approvals.

Historical Stock Returns for Ajooni Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.50%+1.27%+8.99%+2.83%-27.93%-57.54%

How will the construction of new storage godowns impact Ajooni Biotech's operational capacity and revenue growth?

What is the strategic rationale behind Healthy Biosciences increasing its stake through preferential allotment?

How will the increase in authorised share capital support the company's future expansion plans?

More News on Ajooni Biotech

1 Year Returns:-27.93%